PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (March 2019)
PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (March 2019)
This briefing has been compiled to support community pharmacy teams as the reclassification of pregabalin and gabapentin as Schedule 3 Controlled Drugs (CDs) comes into force on 1st April 2019
PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (revised 15/04/2019)
If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.
To browse other PSNC briefings on dispensing and supply click here.
